BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7257329)

  • 21. Therapeutic plasmapheresis; present state and future aspects.
    Gurland HJ; Samtleben W; Blumenstein M
    Life Support Syst; 1983; 1(1):61-70. PubMed ID: 6379316
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of plasmapheresis in active systemic lupus erythematosus.
    Kater L; Derksen RH; Houwert DA; Hené RJ; Struyvenberg A; Gmelig Meyling FH; Verroust P
    Neth J Med; 1981; 24(6):209-16. PubMed ID: 7322246
    [No Abstract]   [Full Text] [Related]  

  • 23. [Plasmapheresis in the treatment of immunological nephropathies].
    Frasca' G; Vangelista A; Nanni Costa A; Cucudis P
    G Clin Med; 1981 Apr; 62(4):260-9. PubMed ID: 7021294
    [No Abstract]   [Full Text] [Related]  

  • 24. [The clinical efficacy of plasmapheresis in the combined therapy of patients with chronic glomerulonephritis and nephrotic syndrome].
    Kolesnik NA; Dudar' IA; Velichko MB
    Urol Nefrol (Mosk); 1993; (6):44-6. PubMed ID: 8160322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Indications for the application of plasmapheresis (author's transl)].
    Samtleben W; Blumenstein M; Habersetzer R; Gurland HJ
    MMW Munch Med Wochenschr; 1982 Jul; 124(27):641-5. PubMed ID: 6810157
    [No Abstract]   [Full Text] [Related]  

  • 26. Retrospective analysis of patients with lupus nephritis: data from a large clinical immunological center in Hungary.
    Brugos B; Kiss E; Szodoray P; Szegedi G; Zeher M
    Scand J Immunol; 2006 Oct; 64(4):433-7. PubMed ID: 16970686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical study on therapeutic plasmapheresis--mechanism of its efficacy, indications, and clinical application. b. Removal of antigen-antibody complex and clinical indications].
    Shiokawa Y
    Nihon Rinsho; 1984 Aug; 42(8):1861-5. PubMed ID: 6392609
    [No Abstract]   [Full Text] [Related]  

  • 28. Short-term plasmapheresis in acute lupus nephritis.
    Vangelista A; Frascà G; Orsi C; Sermasi G; Zucchelli P; Bonomini V
    Int J Artif Organs; 1983 Jul; 6 Suppl 1():43-6. PubMed ID: 6642736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute lung injury as initial manifestation of diffuse alveolar hemorrhage].
    Fernández Fabrellas E; Blanquer Olivas J; Blanquer Olivas R; Simó Mompó M; Chiner Vives E; Ruiz Montalt F
    An Med Interna; 1999 Jun; 16(6):281-4. PubMed ID: 10422296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of plasma exchange and thoracic duct drainage on immunological status in glomerulonephritis.
    Bonomini V; Vangelista A; Stefoni S; Frascà G; Nanni Costa A
    Proc Eur Dial Transplant Assoc; 1981; 18():736-42. PubMed ID: 7330001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunologic therapy for glomerulonephritis with combined immunoadsorption and IVIG therapy].
    Welcker M; Helmke K
    Immun Infekt; 1995 Aug; 23(4):140-1. PubMed ID: 7558119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short and longterm experience with plasmapheresis in connective tissue diseases.
    Dequeker J; Geusens P; Wielands L
    Biomedicine; 1980 Dec; 32(4):189-94. PubMed ID: 7470581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lupus nephritis. 3: Therapeutic approach].
    Guérin S; Léveillé M
    Union Med Can; 1982 Feb; 111(2):91-5, 133. PubMed ID: 7080269
    [No Abstract]   [Full Text] [Related]  

  • 34. [Synchronizing therapy with plasmapheresis and cyclophosphamide in rapidly progressing systemic lupus erythematosis with kidney involvement].
    Demin AA; Sentiakova TN; Smirnov VV; Demina LM; Mamin IV
    Ter Arkh; 1996; 68(5):27-30. PubMed ID: 9082593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Plasmapheresis in the treatment of rapidly progressing glomerulonephritis].
    Milovanov IuS; Komiagin IuV; Nikolaev AIu
    Ter Arkh; 1993; 65(6):27-30. PubMed ID: 8378842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe infections in plasmapheresis-treated systemic lupus erythematosus.
    Aringer M; Smolen JS; Graninger WB
    Arthritis Rheum; 1998 Mar; 41(3):414-20. PubMed ID: 9506568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Double filtration plasma exchange in the treatment of lupus nephritis].
    Tsuda H
    Ryumachi; 1984 Oct; 24(5):345-51. PubMed ID: 6523293
    [No Abstract]   [Full Text] [Related]  

  • 38. [Plasmapheresis in the treatment of rapidly progressing glomerulonephritis].
    Milovanov IuS; Komiagin IuV; Shilov EM; Ermolenko VM
    Ter Arkh; 1989; 61(6):78-81. PubMed ID: 2799722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apheresis is of no value in SLE.
    Hunsicker LG
    Trans Am Soc Artif Intern Organs; 1984; 30():697-9. PubMed ID: 6533963
    [No Abstract]   [Full Text] [Related]  

  • 40. [Plasmapheresis in human therapeutics].
    Kennes B
    Rev Med Brux; 1983 Dec; 4(10):649-57. PubMed ID: 6658248
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.